elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q37728299-D98B45E7-5C04-4FF9-939B-C539966633AC
Q37728299-D98B45E7-5C04-4FF9-939B-C539966633AC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37728299-D98B45E7-5C04-4FF9-939B-C539966633AC
Selective estrogen receptor modulator BC-1 activates antioxidant signaling pathway in vitro via formation of reactive metabolites
P2860
Q37728299-D98B45E7-5C04-4FF9-939B-C539966633AC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37728299-D98B45E7-5C04-4FF9-939B-C539966633AC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
627d52cb2464f85d4655c2ea0d31632c2d9319a2
P2860
Randomized, double-blind, multicenter trial comparing two doses of arzoxifene (LY353381) in hormone-sensitive advanced or metastatic breast cancer patients.